Inhibition of α-glucosidase and amylase by bartogenic acid isolated from Barringtonia racemosa Roxb. seeds

Phytotherapy Research

Volumn 21, Issue 8, 2007, Pages 796-799

  Gowri, P Mangala ^a   Tiwari, Ashok K ^a   Ali, A Zehra ^a   Rao, J Madhusudana ^a  

^a INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

Author keywords

amylase inhibition; glucosidase inhibition; Barringtonia racemosa; Bartogenic acid

Indexed keywords

ALCOHOL; ALPHA GLUCOSIDASE; AMYLASE; BARRINGTONIA RACEMOSA EXTRACT; BARTOGENIC ACID; HEXANE; METHANOL; UNCLASSIFIED DRUG;

ARTICLE; BARRINGTONIA; BARRINGTONIA RACEMOSA; CONCENTRATION RESPONSE; DRUG ISOLATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; NONHUMAN; PLANT SEED;

ALPHA-GLUCOSIDASES; AMYLASES; ANIMALS; BARRINGTONIA; INTESTINES; MOLECULAR STRUCTURE; PLANT EXTRACTS; RATS; SEEDS; TRITERPENES;

BARRINGTONIA RACEMOSA;

EID: 34547650832     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2176     Document Type: Article

References (26)

1. Ali H, Houghton PJ, Soumyanath A. 2006. α-Amylase inhibitory activity of some Malaysian plants used to treat diabetes with particular reference to Phyllanthus amarus. J Ethnopharmacol 107: 449-455.
2. Arramon G, Saucier C, Colombani D, Glories Y. 2002. Identification of triterpene saponins in Quercus robur L. and Q. petraea Liebl. heartwood by LC-ESI/MS and NMR. Phytochem Anal 13: 305-310.
3. Asano N. 2003. Glycosidase inhibitors: update and perspectives on practical use. Glycobiology 13: 93R-104R.
4. Babu KS, Tiwari AK, Srinivas PV, Ali AZ, Raju BC, Rao JM. 2004. Yeast and mammalian a-glucosidase inhibitory constituents from Himalayan Rhubarb Rheum emodi Wall. Ex Meisson. Bioorg Med Chem Lett 14: 3841-3845.
5. Cheng AYY, Josse RG. 2004. Intestinal absorption inhibitors for type II diabetes mellitus: Prevention and treatment. Drug Discov Today Ther Strat 1: 201-206.
6. Chiba S. 1997. Molecular mechanism in alpha-glucosidase and glucoamylase. Biosci Biotechnol Biochem 61: 1233-1239.
7. Deraniyagala SA, Ratnasooriya WD, Goonasekara CL. 2003. Antinociceptive effect and toxicological study of the aqueous bark extract of Barringtonia racemosa on rats. J Ethnopharmocol 86: 21-26.
8. Hasan CM, Khan S, Jabbar A, Rashid MA. 2000. Nasimaluns A and B: neo-clerodane diterpenoids from Barringtonia racemosa. J Nat Prod 63: 410-411.
9. Hooker JD. 1961. The Flora of British India (Indian repr.; Periodical Experts: Delhi, (published by L. Reeve & Co. Ltd.: Kent, England, 1879), Vol. 2 507-508.
10. Jayaweera DMA. 1981. Medicinal Plants III. National Council of Sri Lanka: Colombo, 129.
11. Khan S, Jabbar A, Hasan CM, Rashid MA. 2001. Antibacterial activity of Baringtonia racemosa. Fitoterapia 72: 162-164.
12. Kim JS, Kwon CS, Son KH. 2000. Inhibition of α-glucosidase and amylase by luteolin, a flavonoid. Biosci Biotechnol Biochem 64: 2458-2461.
13. Lysek R, Schutz C, Favre S et al. 2006. Search for α-glucosidase inhibitors: New N-substituted valienamine and conduramine F-1 derivatives Bioorg Med Chem 14: 6255-6282.
14. Mackeen MM, Ali AM, El-Sharkawy SH et al. 1997. Antimicrobial and cytotoxic properties of some Malaysian traditional vegetables. Int J Pharmacog 35: 174-178.
15. McDougall GJ, Shpiro F, Dobson P, Smith P, Blake A, Stewart D. 2005. Different polyphenols components of soft fruits inhibit α-amylase and α-glucosidase. J Agric Food Chem 53: 2760-2766.
16. Nadkarni KM. 1982. Indian Materia Medica (2nd repr. of the 3rd rev. and enlarged ed.), Vol 1: 177. Popular Prakashan Pvt. Ltd.: Bombay, India.
17. Palanakumbura GWR MC, Wijesundera RLC, Deraniyagala SA, Amarasekara AS. 1996. Antifungal activity of Barringtonia ceylanica bark extract. J Natl Council Sci Sri Lanka 24: 279-283.
18. Platt FM, Neiss GR, Reinkensmeier G et al. 1997. Prevention of lysosomal storage in Tay-Sachs mice treated with N-butyldeoxynojirimicin. Science 276: 428-431.
19. Scott LJ, Spencer CM. 2000. Miglitol: A review of its therapeutic potential in type II diabetes mellitus. Drops 59: 521-549.
20. Sorbera LA, Castaner J, Garcia-Capdevila L. 2005. Celgosivir: α-glucosidase inhibitor. Antihepatitis-C virus drug. Drugs Future 30: 545-552.
21. Sun HY, Long LJ, Wu J. 2006. Chemical constituents of mangrove plant Barringtonia racemosa. Zhong Yao Cai 29: 671-672.
22. Suzuki YA, Murata Y, Inui H, Sugiura M, Nakano Y. 2005. Triterpene glycosides from Siraitia grosvenori inhibit rat intestinal maltase and suppress the rise in blood glucose level after a single oral administration of maltose in rats. J Agric Food Chem 53: 2941-2946.
23. Tachibana Y, Kato A, Nishiyama Y et al. 1996. Mitogenic activity in African traditional herbal medicines (Part II). Phytomedicine 2: 335-339.
24. Thomas TJ, Panikkar B, Subramoniyam A, Nair MK, Panikkar KR. 2002. Antitumor property and toxicity of Barringtonia racemosa Roxb. seed extract in mice. J Ethnopharmacol 82: 223-227.
25. Yamagishi S, Nakamura K, Takeuchi M. 2005. Inhibition of postprandial hyperglycemia by acarbose is a promising therapeutic strategy for the treatment of patients with the metabolic syndrome. Med Hypotheses 65: 152-154.
26. Yang Y, Deng Z, Proksch P, Lin W. 2006. Two new 18-en-oleane derivatives from marine mangrove plant, Barringtonia racemosa. Pharmazie 61: 365-366.